Workflow
CareDx(CDNA)
icon
Search documents
CareDx(CDNA) - 2021 Q1 - Quarterly Report
2021-05-04 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 _ ...
CareDx(CDNA) - 2020 Q4 - Earnings Call Presentation
2021-02-26 19:37
The Allo-Transplantation Company Focused on better outcomes through personalized transplant surveillance February 2021 Allo-transplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements ...
CareDx(CDNA) - 2020 Q4 - Earnings Call Transcript
2021-02-25 03:38
Start Time: 16:30 January 1, 0000 5:13 PM ET CareDx, Inc. (NASDAQ:CDNA) Q4 2020 Earnings Conference Call February 24, 2021, 16:30 PM ET Company Participants Reginald Seeto - President and CEO Marcel Konrad - CFO Sham Dholakia - SVP, Medical Affairs and Clinical Operations Greg Chodaczek - Managing Director Conference Call Participants Matthew Andrews - Jefferies Rachel Vatnsdal - Piper Sandler Alex Nowak - Craig-Hallum Capital Group Andrew Cooper - Raymond James Sung-Ji Nam - BTIG Boobalan Pachaiyappan - H. ...
CareDx(CDNA) - 2020 Q4 - Annual Report
2021-02-23 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________ Form 10-K ________________________________________________________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH ...
CareDx(CDNA) - 2020 Q3 - Earnings Call Transcript
2020-11-01 17:07
CareDx, Inc. (NASDAQ:CDNA) Q3 2020 Earnings Conference Call October 29, 2020 5:00 PM ET Company Participants Greg Chodaczek - Managing Director Peter Maag - Chairman and Chief Executive Officer Reginald Seeto - President and Chief Business Officer Michael Bell - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Steven Mah - Paper Sandler Alex Nowak - Craig-Hallum Capital Group Andrew Cooper - Raymond James Sung Ji Nam - BTIG Yi Chen - H.C. Wainwright Operator Greetings and w ...
CareDx(CDNA) - 2020 Q3 - Quarterly Report
2020-10-29 21:11
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-365 ...
CareDx(CDNA) - 2020 Q2 - Earnings Call Presentation
2020-08-07 20:00
| --- | --- | |----------------------------|-------| | | | | The Allo-Transplantation | | | | | | Company | | | Focused on better outcomes | | | through personalized | | | transplant surveillance | | August 2020 Allotransplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species el Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements ...
CareDx(CDNA) - 2020 Q2 - Earnings Call Transcript
2020-08-05 02:44
CareDx, Inc (NASDAQ:CDNA) Q2 2020 Earnings Conference Call August 4, 2020 4:30 PM ET Company Participants Greg Chodaczek - Head of Investor Relations Peter Maag - Chief Executive Officer Michael Bell - Chief Financial Officer Reginald Seeto - Chief Business Officer Conference Call Participants Brandon Couillard - Jefferies & Company, Inc. Rachel Vatnsdal - Piper Sandler Alexander Nowak - Craig-Hallum Capital Group LLC Andrew Cooper - Raymond James & Associates, Inc. Yi Chen - HC Wainwright Operator Greeting ...
CareDx(CDNA) - 2020 Q2 - Quarterly Report
2020-08-04 21:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 __ ...
CareDx (CDNA) Investor Presentation - Slideshow
2020-05-30 15:18
The Allo-Transplantation Company Focused on better outcomes through personalized transplant surveillance. May 2020 Allotransplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regar ...